General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Boehringer Ingelheim(SIGNIFICANT), Daiichi Sankyo(SIGNIFICANT), Bayer Healthcare Pharmaceuticals(SIGNIFICANT), Bristol-Myers Squibb Company (MODEST), Pfizer Inc(MODEST), Janssen Pharmaceuticals, Inc(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Janssen Pharmaceuticals, Inc(SIGNIFICANT), Anthos(SIGNIFICANT), AstraZeneca Pharmaceuticals(SIGNIFICANT), Novartis Corporation(SIGNIFICANT)

View Full Disclosure